A detailed history of Private Advisor Group, LLC transactions in Alpha Tau Medical Ltd. stock. As of the latest transaction made, Private Advisor Group, LLC holds 47,583 shares of DRTS stock, worth $110,392. This represents 0.0% of its overall portfolio holdings.

Number of Shares
47,583
Previous 47,583 -0.0%
Holding current value
$110,392
Previous $120,000 5.83%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$2.05 - $2.9 $22,236 - $31,456
-10,847 Reduced 18.56%
47,583 $120,000
Q4 2023

Feb 06, 2024

BUY
$2.75 - $3.89 $160,682 - $227,292
58,430 New
58,430 $175,000

Others Institutions Holding DRTS

About Alpha Tau Medical Ltd.


  • Ticker DRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,011,296
  • Market Cap $160M
  • Description
  • Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...
More about DRTS
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.